Giwinostat supply
Original notice title
Poland – Various medicinal products – DOSTAWA GIWINOSTATU
Opportunity Score
Why this score?
Opportunity
52 / 100
Complexity
58 / 100
Risk factors
Offer must be submitted through the e-ProPublico platform and confirmed by the final submission action; failure to comp...
Bid security is mandatory and must be provided in one of the accepted forms before the deadline.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Tender facts
- Contracting authority
- Uniwersytecki Dziecięcy Szpital Kliniczny im. L. Zamenhofa w Białymstoku
- Country
- Poland
- CPV
- 33690000 - Various medicinal products
- Deadline
- Aug 18, 2026
Overview
Moderate opportunityKey Facts
- Supplies contract
- 1 lot
- Duration 12 MONTH
- Supply of giwinostat medicinal product to the University Children’s Clinical Hospital in Białystok.
- The lot concerns an oral suspension formulation specified as Givinostati hydrochloridum monohydricum 8.86 mg/ml, 140 ml, OP 40.
Show full summary
Open EU-level supply tender for one lot: delivery of giwinostat to the University Children’s Clinical Hospital in Białystok, Poland. Award is price-only. Electronic submission via e-ProPublico is required. The notice includes explicit bid security and pharmaceutical authorization requirements. No contract value is provided in the structured data or XML notice.
Risks
Offer must be submitted through the e-ProPublico platform and confirmed by the final submission action; failure to comp...
Bid security is mandatory and must be provided in one of the accepted forms before the deadline.
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- If signatory authority is not evident from registry data, a power of attorney must be attached.
Administrative
- Offer must be submitted electronically via e-ProPublico.
- Offer must be signed with a valid qualified electronic signature by authorized persons.
Award Criteria
Lot 1
Buyer
Location
Białystok, POL
Website
Buyer profile
Identifier
542-25-34-063
Activity
Health
Lots (1)
LOT-0001
Giwinostat supply
Supply of giwinostat oral suspension to the hospital in Białystok. The lot description specifies 8.86 mg/ml oral suspension, 140 ml, pack OP 40. Performance location is Białystok, Poland. The lot information comes from structured data and XML notice.
Location
Duration
Category
Award Criteria
Deadline
Award details
Liczba punktów = ( Cmin/Cof ) * 100 * waga gdzie: - Cmin - najniższa cena spośród wszystkich ofert - Cof - cena podana w ofercie
Value note
Show original TED data
Original lot title
Dostawa giwinostatu
Original TED description
1 Givinostati hydrochloridum monohydricum 8,86 mg/ml zawiesina doustna 140 ml OP 40
Procurement Details
- Publication date
- 06 Jul 2026
- Languages
- Polish
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 465320-2026
Documents (1)
Similar tenders
Spain – Various medicinal products – Suministro de medicamentos destinado a terapias genicas mediante SDA
Italy – Various medicinal products – Bando V SDA farmaci
Bulgaria – Pharmaceutical products – Доставка на лекарствени продукти за нуждите на КОЦ-Русе ЕООД
Italy – Various medicinal products – ARIA_2025_045
Bulgaria – Pharmaceutical products – Доставка на лекарствени продукти за нуждите на УМБАЛ "Царица Йоанна-ИСУЛ" ЕАД
Italy – Various medicinal products – Bando SDA Farmaci, Emoderivati, Vaccini e Mezzi di contrasto - Terza edizione
Opportunity Score
Why this score?
Opportunity
52 / 100
Complexity
58 / 100
Risk factors
Offer must be submitted through the e-ProPublico platform and confirmed by the final submission action; failure to comp...
Bid security is mandatory and must be provided in one of the accepted forms before the deadline.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications